Published in Medical Letter on the CDC and FDA, February 19th, 1996
In a series of slide presentations, researchers conducting clinical trials of HIV protease inhibitors showed that the most potent of these compounds can significantly delay the onset of AIDS and prolong survival.
The drugs do not cure AIDS. But they do provide the first major step toward the goal of making HIV infection a manageable condition.
This sea of change in AIDS therapy was announced in presentations made at the 3rd Conference on Retroviruses and Opportunistic Infections, held January 28-February 1, 1996, in Washington,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.